Banque Cantonale Vaudoise Genfit S.A. Call Options Transaction History
Banque Cantonale Vaudoise
- $2.43 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GNFT
# of Institutions
6Shares Held
29.3KCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny166KShares$698,7750.0% of portfolio
-
Morgan Stanley New York, NY34.7KShares$145,8240.0% of portfolio
-
Ubs Group Ag3.05KShares$12,8010.0% of portfolio
-
Rhumbline Advisers Boston, MA678Shares$2,8470.0% of portfolio
-
Optiver Holding B.V. Amsterdam, P7266Shares$1,1170.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $209M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...